$36.05
+0.75 (+2.12%)
MDLN News2 articles
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline Inc. shareholders sold 72.55 million Class A shares at $37 each in an upsized secondary offering, with the stock closing at $37.01 on Friday. The deal closes May 28.
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline's $2.68 billion secondary offering, upsized from 60 million shares, prices at $37 each, with the stock holding near that level.